
Esophageal Cancer
Latest News

Video Series

Latest Videos
Shorts
More News

A diagnosis of esophageal cancer can bring up many questions and concerns. Our goal is to provide you with clear, accurate and educational information.

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing research to improve patient outcomes.

Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo in the RATIONALE-306 trial.

End-of-life palliative care consultations may also ease financial strain for patients with esophageal cancer.

Among patients with advanced gastric and GEJ cancer, or esophageal adenocarcinoma, treatment with first-line Opdivo and chemo demonstrated deep responses.

In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved survival versus surgery alone.

I feel most thankful on Father's Day, especially after being told I'd never be able to have children.

Perioperative chemotherapy with chemotherapy led to improved survival outcomes versus neoadjuvant chemoradiation in resectable esophageal cancer.

Research has shown aspirin use to be associated with lower rates of metastasis for some patients.

I've found that nutrition and healthy foods play an important role during cancer.

There is no difference in recovery, complication or cost between the two most common surgical approaches for esophageal cancer.

When I was my husband's caregiver, I tried to make things comfortable, but I'm not sure if the drugs and bedpans could ever make it right.

The GI cancer space has “made huge strides” in recent years, which opened more options for patients with a type of esophageal cancer, an expert said.

The Food and Drug Administration approved Tevimbra for pretreated metastatic or unresectable esophageal squamous cell carcinoma.

This past holiday season made me realize that I feel a strong sense of fulfillment as a cancer survivor and caregiver.

Simultaneous administration of the novel oral S-1 chemotherapy and SIB-RT could improve survival rates for patients aged 70 and older with esophageal squamous cell carcinoma (ESCC).

The hold has been placed due to visual side effects in a number of patients with solid tumors.














